Skip to main content
Top
Published in: Current Anesthesiology Reports 2/2016

01-06-2016 | Neuromuscular Blockade (GS Murphy, Section Editor)

The Use of Sugammadex in Clinical Practice: Which Patients Are Most Likely to Benefit?

Author: Thomas Fuchs-Buder

Published in: Current Anesthesiology Reports | Issue 2/2016

Login to get access

Abstract

The main advantage of sugammadex-based reversal compared with the “classical” acetylcholinesterase inhibitor-based concept is that it achieves more rapid and more reliable recovery and has the unique ability to dose-dependently reverse any degree of neuromuscular block. Mainly because of economic reasons, sugammadex is often limited to patient groups or procedures that are most likely to benefit from its unique features. In this context, patients with myasthenia gravis, patients undergoing (abdominal) laparoscopic surgery, patients undergoing short-acting procedures that require neuromuscular blockade, obese, elderly, or patients undergoing rapid sequence induction are most often cited. However, at comparable costs, this arbitrary limitation of sugammadex could be abolished.
Literature
1.
go back to reference Murphy GS, Szokol JW, Marymont JH, et al. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg. 2008;107:130–7.CrossRef Murphy GS, Szokol JW, Marymont JH, et al. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg. 2008;107:130–7.CrossRef
2.
go back to reference Murphy GS, Szokol JW, Avram MJ, et al. Intraoperative acceleromyography monitoring reduces symptoms of muscle weakness and improves quality of recovery in the early postoperative period. Anesthesiology. 2011;115:946–54.CrossRef Murphy GS, Szokol JW, Avram MJ, et al. Intraoperative acceleromyography monitoring reduces symptoms of muscle weakness and improves quality of recovery in the early postoperative period. Anesthesiology. 2011;115:946–54.CrossRef
3.
go back to reference Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology. 2003;98:1042–8.CrossRef Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology. 2003;98:1042–8.CrossRef
4.
go back to reference Plaud B, Debaene B, Donati F, Marty J. Residual paralysis after emergence from anesthesia. Anesthesiology. 2010;112:1013–22.CrossRef Plaud B, Debaene B, Donati F, Marty J. Residual paralysis after emergence from anesthesia. Anesthesiology. 2010;112:1013–22.CrossRef
5.
go back to reference Meistelman C, Fuchs-Buder T, Raft J. Sugammadex development and use in clinical practice. Curr Anesthesiol Rep. 2013;3:122–9.CrossRef Meistelman C, Fuchs-Buder T, Raft J. Sugammadex development and use in clinical practice. Curr Anesthesiol Rep. 2013;3:122–9.CrossRef
6.
go back to reference Zhang MQ. Drug-specific cyclodextrines: the future of rapid neuromuscular drug reversal? Drugs Future. 2003;28(347):54. Zhang MQ. Drug-specific cyclodextrines: the future of rapid neuromuscular drug reversal? Drugs Future. 2003;28(347):54.
7.
go back to reference Bom A, Bradley M, Cameron K, et al. A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Eng. 2002;41:266–70. Bom A, Bradley M, Cameron K, et al. A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Eng. 2002;41:266–70.
8.
go back to reference Sorgenfrei IF, Norrild K, Larsen PB, et al. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. Anesthesiology. 2006;104:555–62.CrossRef Sorgenfrei IF, Norrild K, Larsen PB, et al. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. Anesthesiology. 2006;104:555–62.CrossRef
9.
go back to reference Gijsenbergh F, Ramael S, Houwing N, van Iersel T. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology. 2005;103:695–703.CrossRef Gijsenbergh F, Ramael S, Houwing N, van Iersel T. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology. 2005;103:695–703.CrossRef
10.
go back to reference Groudine SB, Soto R, Lien C, Drover D, Roberts K. A randomized, dose-finding, phase II study of the selective relaxant binding drug, sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block. Anesth Analg. 2007;104:555–62.CrossRef Groudine SB, Soto R, Lien C, Drover D, Roberts K. A randomized, dose-finding, phase II study of the selective relaxant binding drug, sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block. Anesth Analg. 2007;104:555–62.CrossRef
11.
go back to reference Vanacker BF, Vermeyen KM, Struys MM, et al. Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane. Anesth Analg. 2007;104:563–8.CrossRef Vanacker BF, Vermeyen KM, Struys MM, et al. Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane. Anesth Analg. 2007;104:563–8.CrossRef
12.
go back to reference Lee C, Jahr JS, Candiotti KA, et al. Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium: a comparison with spontaneous recovery from succinylcholine. Anesthesiology. 2009;110:1020–5.CrossRef Lee C, Jahr JS, Candiotti KA, et al. Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium: a comparison with spontaneous recovery from succinylcholine. Anesthesiology. 2009;110:1020–5.CrossRef
13.
go back to reference De Boer HD, van Egmond J, Driessen JJ, Booij LH. A new approach to anesthesia management in myasthenia gravis: reversal of neuromuscular blockade by sugammadex. Rev Esp Anesthesiol Reanim. 2010;57:181–4.CrossRef De Boer HD, van Egmond J, Driessen JJ, Booij LH. A new approach to anesthesia management in myasthenia gravis: reversal of neuromuscular blockade by sugammadex. Rev Esp Anesthesiol Reanim. 2010;57:181–4.CrossRef
14.
go back to reference Petrun AM, Mekis D, Kamenik M. Successful use of rocuronium and sugammadex in a patient with myasthenia. Eur J Anaesthesiol. 2010;27:917–8.CrossRef Petrun AM, Mekis D, Kamenik M. Successful use of rocuronium and sugammadex in a patient with myasthenia. Eur J Anaesthesiol. 2010;27:917–8.CrossRef
15.
go back to reference Naguib M, Flood P, McArdle JJ, Brenner HR. Advances in neurobiology of the neuromuscular junction. Implications for the anaesthesiologist. Anesthesiology. 2002;96:202–31.CrossRef Naguib M, Flood P, McArdle JJ, Brenner HR. Advances in neurobiology of the neuromuscular junction. Implications for the anaesthesiologist. Anesthesiology. 2002;96:202–31.CrossRef
16.
go back to reference De Boer HD, Fuchs-Buder T. Residual neuromuscular blockade and myasthenia gravis. Acta Anaesthesiol Scand. 2012;56:932–3.CrossRef De Boer HD, Fuchs-Buder T. Residual neuromuscular blockade and myasthenia gravis. Acta Anaesthesiol Scand. 2012;56:932–3.CrossRef
17.
go back to reference de Boer HD, van Egmond J, Driessen JJ. Sugammadex in patients with myasthenia gravis. Anaesthesia. 2010;65:653.CrossRef de Boer HD, van Egmond J, Driessen JJ. Sugammadex in patients with myasthenia gravis. Anaesthesia. 2010;65:653.CrossRef
18.
go back to reference Fujimoto M, Teraski S, Nishi M, Yamamoto T. Response to rocuronium and its determinants in patients with myasthenia gravis: A case-control study. Eur J Anaesthesiol. 2015;32:672–80.CrossRef Fujimoto M, Teraski S, Nishi M, Yamamoto T. Response to rocuronium and its determinants in patients with myasthenia gravis: A case-control study. Eur J Anaesthesiol. 2015;32:672–80.CrossRef
19.
go back to reference • De Boer HD, Shields MO, Booij LH. Reversal of neuromuscular blockade with sugammadex in patients with myasthenia gravis: a case series of 21 patients and review of the literature. Eur J Anaesthesiol. 2014;31:715–21. The article gives a complete overview over the topic. • De Boer HD, Shields MO, Booij LH. Reversal of neuromuscular blockade with sugammadex in patients with myasthenia gravis: a case series of 21 patients and review of the literature. Eur J Anaesthesiol. 2014;31:715–21. The article gives a complete overview over the topic.
20.
go back to reference Yamaguchi S, Ohno G, Kitamura J. Successful anesthetic management of laparoscopic rectopexy using rocuronium and sugammadex in a patient with Becker muscular dystrophy. Masui. 2014;63:1131–4.PubMed Yamaguchi S, Ohno G, Kitamura J. Successful anesthetic management of laparoscopic rectopexy using rocuronium and sugammadex in a patient with Becker muscular dystrophy. Masui. 2014;63:1131–4.PubMed
21.
go back to reference Matsuki Y, Hirose M, Tabata M, Nobukawa Y, Shigemi K. The use of sugammadex in a patient with myotonic dystrophy. Eur J Anaesthesiol. 2011;28:145–6.CrossRef Matsuki Y, Hirose M, Tabata M, Nobukawa Y, Shigemi K. The use of sugammadex in a patient with myotonic dystrophy. Eur J Anaesthesiol. 2011;28:145–6.CrossRef
22.
go back to reference Dell-Kuster S, Levano S, Burkhart CS, et al. Predictors of the variability in neuromuscular block duration following succinylcholine. A prospective, observational study. Eur J Anaesthesiol. 2015;32:687–96.CrossRef Dell-Kuster S, Levano S, Burkhart CS, et al. Predictors of the variability in neuromuscular block duration following succinylcholine. A prospective, observational study. Eur J Anaesthesiol. 2015;32:687–96.CrossRef
23.
go back to reference Fuchs-Buder T, Schmartz D. The never ending story or the search for a nondepolarising alternative to succinylcholine. Eur J Anaesthesiol. 2013;30:583–4.CrossRef Fuchs-Buder T, Schmartz D. The never ending story or the search for a nondepolarising alternative to succinylcholine. Eur J Anaesthesiol. 2013;30:583–4.CrossRef
25.
go back to reference Pühringer FK, Rex C, Sielenkämper AW, et al. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points. An international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. Anesthesiology. 2008;109:188–97.CrossRef Pühringer FK, Rex C, Sielenkämper AW, et al. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points. An international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. Anesthesiology. 2008;109:188–97.CrossRef
26.
go back to reference Sorensen MK, Bretlau C, Gätke MR, et al. Rapid sequence induction and intubation with rocuronium-sugammadex compared with succinylcholine. a randomised trial. Br J Anaesth. 2012;108:682–9.CrossRef Sorensen MK, Bretlau C, Gätke MR, et al. Rapid sequence induction and intubation with rocuronium-sugammadex compared with succinylcholine. a randomised trial. Br J Anaesth. 2012;108:682–9.CrossRef
27.
go back to reference Bisschops MMA, Hollemann C, Huitink JM. Can sugammadex save a patients in simulated „cannot intubate, cannot ventilate“situation? Anaesthesia. 2010;65:936–41.CrossRef Bisschops MMA, Hollemann C, Huitink JM. Can sugammadex save a patients in simulated „cannot intubate, cannot ventilate“situation? Anaesthesia. 2010;65:936–41.CrossRef
28.
go back to reference Fernando PU, Viby-Mogensen J, Bonsu AK, et al. Relationsip between posttetanic count and response to carinal stimulation during vecuronium-induced neuromuscular blockade. Acta Anaesthesiol Scand. 1987;31:593–6.CrossRef Fernando PU, Viby-Mogensen J, Bonsu AK, et al. Relationsip between posttetanic count and response to carinal stimulation during vecuronium-induced neuromuscular blockade. Acta Anaesthesiol Scand. 1987;31:593–6.CrossRef
29.
go back to reference Blobner M, Frick CG, Stäuble RB, et al. Neuromuscular blockade improves surgical conditions (NISCO). Surg Endosc. 2015;29:627–36.CrossRef Blobner M, Frick CG, Stäuble RB, et al. Neuromuscular blockade improves surgical conditions (NISCO). Surg Endosc. 2015;29:627–36.CrossRef
30.
go back to reference Jones RK, Caldwell JE, Brull SJ, Soto RG. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine. Anesthesiology. 2008;109:816–24.CrossRef Jones RK, Caldwell JE, Brull SJ, Soto RG. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine. Anesthesiology. 2008;109:816–24.CrossRef
31.
go back to reference De Souza CM, Tardelli MA, Tedesco H, et al. Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end stage renal disease: A comparative prospective clinical trial. Eur J Anaesthesiol. 2015;32:681–6.CrossRef De Souza CM, Tardelli MA, Tedesco H, et al. Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end stage renal disease: A comparative prospective clinical trial. Eur J Anaesthesiol. 2015;32:681–6.CrossRef
32.
go back to reference Mirzakhani H, Welch CA, Eikermann M, Nozari A. Neuromuscular blocking agents for electroconvulsive therapy: a systematic review. Acta Anaesthesiol Scand. 2012;56:3–16.CrossRef Mirzakhani H, Welch CA, Eikermann M, Nozari A. Neuromuscular blocking agents for electroconvulsive therapy: a systematic review. Acta Anaesthesiol Scand. 2012;56:3–16.CrossRef
34.
go back to reference Boyce JR, Ness T, Castroman P, Gleysteen JJ. A preliminary study of the optimal anesthesia positioning for the morbidly obese patient. Obes Surg. 2003;13:4–9.CrossRef Boyce JR, Ness T, Castroman P, Gleysteen JJ. A preliminary study of the optimal anesthesia positioning for the morbidly obese patient. Obes Surg. 2003;13:4–9.CrossRef
35.
go back to reference Gambee AM, Hertzka RE, Fisher DM, et al. Preoxygenation techniques: comparison of three minutes and four breaths. Anesth Analg. 1987;66:468–70.CrossRef Gambee AM, Hertzka RE, Fisher DM, et al. Preoxygenation techniques: comparison of three minutes and four breaths. Anesth Analg. 1987;66:468–70.CrossRef
36.
go back to reference Herbstreit F, Peters J, Eikermann M. Impaired upper airway integrity by residual neuromuscular blockade: increased airway collapsibility and blunted genioglossus muscle activity in response to negative pharyngeal pressure. Anesthesiology. 2009;110:253–60.CrossRef Herbstreit F, Peters J, Eikermann M. Impaired upper airway integrity by residual neuromuscular blockade: increased airway collapsibility and blunted genioglossus muscle activity in response to negative pharyngeal pressure. Anesthesiology. 2009;110:253–60.CrossRef
37.
go back to reference Pansard JL, Chauvin M, Lebrault C, Gauneau P, Duvaldestin P. Effects of an intubating dose of succinylcholine and atracurium on the diaphragm and the adductor pollicis muscle in humans. Anesthesiology. 1987;67:326–30.CrossRef Pansard JL, Chauvin M, Lebrault C, Gauneau P, Duvaldestin P. Effects of an intubating dose of succinylcholine and atracurium on the diaphragm and the adductor pollicis muscle in humans. Anesthesiology. 1987;67:326–30.CrossRef
38.
go back to reference Meistelman C, Plaud B, Donati F. Rocuronium (ORG 9426) neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis in humans. Can J Anaesth. 1992;39:665–9.CrossRef Meistelman C, Plaud B, Donati F. Rocuronium (ORG 9426) neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis in humans. Can J Anaesth. 1992;39:665–9.CrossRef
39.
go back to reference Carron M, Veronese S, Foletto M, Ori C. Sugammadex allows fast-track bariatric surgery. Obes Surg. 2013;23:1558–63.CrossRef Carron M, Veronese S, Foletto M, Ori C. Sugammadex allows fast-track bariatric surgery. Obes Surg. 2013;23:1558–63.CrossRef
41.
go back to reference • Murphy GS, Szokol JW, Avram MJ, et al. Residual neuromuscular block in the elderly: incidence and clinical implications. Anesthesiology 2015;123:1322–36. The article summarizes the risk of residual paralysis in the elderly. • Murphy GS, Szokol JW, Avram MJ, et al. Residual neuromuscular block in the elderly: incidence and clinical implications. Anesthesiology 2015;123:1322–36. The article summarizes the risk of residual paralysis in the elderly.
42.
go back to reference • Hardemark Cedborg AI, Sundman E, Boden K, et al. Pharyngeal function and breathing pattern during partial neuromuscular block in elderly. Effects on airway protection. Anesthesiology 2014;120:12–25. Gives new insights in paryngeal function in elderly and expands our understanding. • Hardemark Cedborg AI, Sundman E, Boden K, et al. Pharyngeal function and breathing pattern during partial neuromuscular block in elderly. Effects on airway protection. Anesthesiology 2014;120:12–25. Gives new insights in paryngeal function in elderly and expands our understanding.
43.
go back to reference Brueckmann B, Sasaki N, Grobara P, et al. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study. Br J Anaesth. 2015;115:743–51.CrossRef Brueckmann B, Sasaki N, Grobara P, et al. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study. Br J Anaesth. 2015;115:743–51.CrossRef
44.
go back to reference Ledowski T, Falke L, Johnston F, et al. Retrospective investigation of postoperative outcome after reversal of residual neuromuscular blockade: sugammadex, neostigmine or no reversal. Eur J Anaesthesiol. 2014;31:423–9.CrossRef Ledowski T, Falke L, Johnston F, et al. Retrospective investigation of postoperative outcome after reversal of residual neuromuscular blockade: sugammadex, neostigmine or no reversal. Eur J Anaesthesiol. 2014;31:423–9.CrossRef
45.
go back to reference Kopman AF. Neostigmine versus sugammadex: which, when, and how much? Anesthesiology. 2010;113:1010–1.CrossRef Kopman AF. Neostigmine versus sugammadex: which, when, and how much? Anesthesiology. 2010;113:1010–1.CrossRef
Metadata
Title
The Use of Sugammadex in Clinical Practice: Which Patients Are Most Likely to Benefit?
Author
Thomas Fuchs-Buder
Publication date
01-06-2016
Publisher
Springer US
Published in
Current Anesthesiology Reports / Issue 2/2016
Electronic ISSN: 2167-6275
DOI
https://doi.org/10.1007/s40140-016-0157-6

Other articles of this Issue 2/2016

Current Anesthesiology Reports 2/2016 Go to the issue

Thoracic Anesthesia (T Schilling, Section Editor)

Imaging in Thoracic Surgery

Thoracic Anesthesia (T Schilling, Section Editor)

Breathing Through a Straw: Considerations for Tracheal Stenosis Surgery

Thoracic Anesthesia (T Schilling, Section Editor)

New Fast-Track Concepts in Thoracic Surgery: Anesthetic Implications

Thoracic Anesthesia (T Schilling, Section Editor)

Thoracic Anesthesia: A Review of Current Topics and Debates

Thoracic Anesthesia (T Schilling, Section Editor)

Modern Bronchial Blockers in Thoracic Surgery